Rotate Your Device

This site doesn't support landscape mode. Please rotate your phone to portrait.

Vumedi

Vumedi

Vumedi is the largest video education platform for doctors worldwide, dedicated to advancing medical education through innovative video-based learning. Our mission is to empower healthcare professionals by providing them with access to the latest clinical knowledge and surgical techniques from experts around the globe. We curate a vast library of high-quality educational content, enabling users to enhance their skills, stay informed about industry trends, and improve patient outcomes. We are headquartered in Oakland, CA, and have additional offices in Minneapolis, MN, and Zagreb, Croatia.

Oakland, California, United States201-500 employeesFounded 2008

Overview

VuMedi is the YouTube for Surgeons. VuMedi has built the largest physician communities in the fields of Orthopaedics, Cardiovascular, Neurosurgery, Radiology, and others. VuMedi is the central place for surgeons to watch techniques, discuss challenging patients and improve the care of their patients. Being a surgeon is hard. The typical surgeon needs to know how to do 100 different procedures, but performs each procedure only once or twice a year. How does a surgeon prepare, review and stay up to date? In the past is they read textbooks, watched DVDs, attended conferences, and talked with colleagues. Now, they use VuMedi. VuMedi makes meaning: patients worldwide have less complications and better outcomes thanks to VuMedi.

Tech Stack

Viewport metaIphone / mobile compatibleDnssecApple mobile web clips iconHstsMobile non scaleable contentLetsencryptNginxOrganization schemaGoogle cloudHtml5LightboxVimeoJqueryGoogle fontsAmazon ec2Google analyticsBootstrapDigicertF5 nginxAmazon AWSBootstrap FrameworkDjangoDoubleClickFullStoryGmailGoogle AdSenseGoogle AnalyticsGoogle AppsGoogle Tag ManagerLinkedin LoginLinkedin WidgetMailchimp MandrillMobile FriendlyNginxRemoteRoute 53SalesforceUbuntuZencoderReCAPTCHA

Funding History

Seed Round

$834K

Aug 2012

Series A

$1.3M

Jan 2018

Series B

$80.0M

May 2025